Skip to content
10-Q

Quarterly Report

iTeos Therapeutics, Inc.

0000950170-24-124548

← back to feed
Filed
Nov 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 30, 2024 36.53M sh
Shares Diluted Q3 2024 · Sep 30, 2024 43.14M sh
Shares Diluted Q3 2024 · Sep 30, 2024 39.57M sh
Shares Diluted Q3 2024 · Sep 30, 2023 35.78M sh
Shares Diluted Q3 2024 · Sep 30, 2023 35.76M sh
Capex Q3 2024 · Sep 30, 2024 $1.48M
Capex Q3 2024 · Sep 30, 2023 $1.57M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$103.68M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$89.99M
Short Term Investments Q3 2024 · Sep 30, 2024 $364.97M
Short Term Investments Q3 2024 · Dec 31, 2023 $280.74M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $123.74M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $251.18M
Stockholders Equity Q3 2024 · Sep 30, 2024 $631.69M
Stockholders Equity Q3 2024 · Jun 30, 2024 $663.87M
Stockholders Equity Q3 2024 · Mar 31, 2024 $541.2M
Stockholders Equity Q3 2024 · Dec 31, 2023 $575.23M
Stockholders Equity Q3 2024 · Sep 30, 2023 $598.26M
Stockholders Equity Q3 2024 · Jun 30, 2023 $623.53M
Stockholders Equity Q3 2024 · Mar 31, 2023 $652.26M
Stockholders Equity Q3 2024 · Dec 31, 2022 $663.33M
Current Liabilities Q3 2024 · Sep 30, 2024 $36.81M
Current Liabilities Q3 2024 · Dec 31, 2023 $40.01M
Total Liabilities Q3 2024 · Sep 30, 2024 $91.39M
Total Liabilities Q3 2024 · Dec 31, 2023 $92.36M
Current Assets Q3 2024 · Sep 30, 2024 $544.88M
Current Assets Q3 2024 · Dec 31, 2023 $550.65M
Total Assets Q3 2024 · Sep 30, 2024 $723.08M
Total Assets Q3 2024 · Dec 31, 2023 $667.59M
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.05
Eps Diluted Q3 2024 · Sep 30, 2024 −$2.29
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.90
Eps Diluted Q3 2024 · Sep 30, 2023 −$2.30
Eps Basic Q3 2024 · Sep 30, 2024 −$1.05
Eps Basic Q3 2024 · Sep 30, 2024 −$2.29
Eps Basic Q3 2024 · Sep 30, 2023 −$0.90
Eps Basic Q3 2024 · Sep 30, 2023 −$2.30
Sga Expense Q3 2024 · Sep 30, 2024 $12.11M
Sga Expense Q3 2024 · Sep 30, 2024 $37.27M
Sga Expense Q3 2024 · Sep 30, 2023 $12.64M
Sga Expense Q3 2024 · Sep 30, 2023 $38.03M
Rd Expense Q3 2024 · Sep 30, 2024 $36.69M
Rd Expense Q3 2024 · Sep 30, 2024 $107.92M
Rd Expense Q3 2024 · Sep 30, 2023 $30.64M
Rd Expense Q3 2024 · Sep 30, 2023 $85.52M
Net Income Q3 2024 · Sep 30, 2024 −$45.36M
Net Income Q3 2024 · Sep 30, 2024 −$90.7M
Net Income Q3 2024 · Jun 30, 2024 −$7.13M
Net Income Q3 2024 · Mar 31, 2024 −$38.22M
Net Income Q3 2024 · Sep 30, 2023 −$32.24M
Net Income Q3 2024 · Sep 30, 2023 −$82.09M
Net Income Q3 2024 · Jun 30, 2023 −$34.3M
Net Income Q3 2024 · Mar 31, 2023 −$15.55M
Operating Income Q3 2024 · Sep 30, 2024 −$48.8M
Operating Income Q3 2024 · Sep 30, 2024 −$110.2M
Operating Income Q3 2024 · Sep 30, 2023 −$43.28M
Operating Income Q3 2024 · Sep 30, 2023 −$110.96M
Revenue Q3 2024 · Sep 30, 2024 $0
Revenue Q3 2024 · Sep 30, 2024 $35M
Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2023 $12.6M